Close Menu

Cancer Genetics

The private placement follows a restructuring undertaken earlier this year by the molecular diagnostics firm.

GSK and Abbott will develop a companion diagnostic for GSK's investigational MAGE-A3 immunotherapy. After discussions with the FDA, GSK believes the drug and diagnostic will be reviewed simultaneously, and labeling language for the drug will require genetic testing prior to treatment.

Snippets: Apr 1, 2009

Premium

Epigenomics, Response Genetics, Exact Sciences

The firm's Q4 revenues dropped 41 percent, but it noted that test sales are up in the first quarter.

The company said that shuttering the UK facility will save it around $2.3 million in annual expenses.

Snippets: Feb 4, 2009

Premium

National Institutes of Health, Genomic Health, Decode Genetics, Myriad Genetics, Exact Sciences, and more …

Roche will use Response Genetics' technology to assess a HER2 expression test.

Pages

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.